Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence van Hunsel

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Drug Safety - Case Reports|November 28, 2016
Unbearable Pruritus After Withdrawal of (Levo)cetirizineCorine Ekhart, Petra van der Horst, Florence van Hunsel
Drug Safety|February 19, 2021
Assessing the Impact on Health of Pharmacovigilance Activities: Example of Four Safety SignalsFlorence van Hunsel, Laura Peters, Helga Gardarsdottir, et al.
Pharmacoepidemiology and Drug Safety|January 31, 2025
Impact of Regulatory Action on Dose Maximalization for Vitamin B6 Dietary Supplements on the Reporting Pattern for NeuropathyFlorence van Hunsel, Joep Scholl, Misha Vrolijk, et al.
Drug Safety|September 29, 2020
Patient Organizations' Barriers in Pharmacovigilance and Strategies to Stimulate Their ParticipationKatherine Chinchilla, Cristiano Matos, Victoria Hall, et al.
Drug Safety|April 7, 2022
Drug-Induced Sexual Dysfunction: An Analysis of Reports to a National Pharmacovigilance DatabaseCarolina Valeiro, Cristiano Matos, Joep Scholl, et al.
Drug Safety|March 22, 2022
Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine BrandsAgnes Kant, Jurriaan Jansen, Leontine van Balveren, et al.
British Journal of Clinical Pharmacology|October 21, 2020
Red yeast rice (Monascus purpureus) supplements: Case series assessment of spontaneously reported cases to The Netherlands Pharmacovigilance Centre LarebMisha F Vrolijk, Sonja van de Koppel, Florence van Hunsel
Drug Safety|May 6, 2016
The Impact of Experiencing Adverse Drug Reactions on the Patient's Quality of Life: A Retrospective Cross-Sectional Study in the NetherlandsLeàn Rolfes, Florence van Hunsel, Katja Taxis, et al.
Pharmacoepidemiology and Drug Safety|May 20, 2016
The validity and reliability of a signal impact assessment toolLeàn Rolfes, Judith Kolfschoten, Florence van Hunsel, et al.
Vaccine|January 18, 2011
Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoringLinda Härmark, Florence van Hunsel, Eelko Hak, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Drug Safety - Case Reports|November 28, 2016
Unbearable Pruritus After Withdrawal of (Levo)cetirizineCorine Ekhart, Petra van der Horst, Florence van Hunsel
Drug Safety|February 19, 2021
Assessing the Impact on Health of Pharmacovigilance Activities: Example of Four Safety SignalsFlorence van Hunsel, Laura Peters, Helga Gardarsdottir, et al.
Pharmacoepidemiology and Drug Safety|January 31, 2025
Impact of Regulatory Action on Dose Maximalization for Vitamin B6 Dietary Supplements on the Reporting Pattern for NeuropathyFlorence van Hunsel, Joep Scholl, Misha Vrolijk, et al.
Drug Safety|September 29, 2020
Patient Organizations' Barriers in Pharmacovigilance and Strategies to Stimulate Their ParticipationKatherine Chinchilla, Cristiano Matos, Victoria Hall, et al.
Drug Safety|April 7, 2022
Drug-Induced Sexual Dysfunction: An Analysis of Reports to a National Pharmacovigilance DatabaseCarolina Valeiro, Cristiano Matos, Joep Scholl, et al.
Drug Safety|March 22, 2022
Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine BrandsAgnes Kant, Jurriaan Jansen, Leontine van Balveren, et al.
British Journal of Clinical Pharmacology|October 21, 2020
Red yeast rice (Monascus purpureus) supplements: Case series assessment of spontaneously reported cases to The Netherlands Pharmacovigilance Centre LarebMisha F Vrolijk, Sonja van de Koppel, Florence van Hunsel
Drug Safety|May 6, 2016
The Impact of Experiencing Adverse Drug Reactions on the Patient's Quality of Life: A Retrospective Cross-Sectional Study in the NetherlandsLeàn Rolfes, Florence van Hunsel, Katja Taxis, et al.
Pharmacoepidemiology and Drug Safety|May 20, 2016
The validity and reliability of a signal impact assessment toolLeàn Rolfes, Judith Kolfschoten, Florence van Hunsel, et al.
Vaccine|January 18, 2011
Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoringLinda Härmark, Florence van Hunsel, Eelko Hak, et al.
Pageof 10